Experiences of using Aflibercept in diabetic macular edema treatment: data from routine clinical practice
Purpose. To assess the effectiveness and safety of intravitreal aflibercept injections in clinically significant diabetic macular edema (DME) in a routine clinical practice.Material and methods. This was a prospective, observational, single-center study. During the study, anti-VEGF treatment naïve p...
Saved in:
| Main Author: | E. Yu. Santoro |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Real Time Ltd
2018-12-01
|
| Series: | Российский офтальмологический журнал |
| Subjects: | |
| Online Access: | https://roj.igb.ru/jour/article/view/198 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Changes of retinal ganglion cell–inner plexiform layer thickness and visual acuity in patients with diabetic macular edema treated with Aflibercept
by: Mouna M. Alsaad, et al.
Published: (2025-01-01) -
Comparative Efficacy of Intravitreal Aflibercept and Dexamethasone Implant in Treating Macular Edema Associated with Diabetic Retinopathy or Retinal Vein Occlusion: A Meta-Analysis and Systematic Review
by: Khaled Moghib, et al.
Published: (2025-01-01) -
One-year results of visual response following intravitreal novel anti-VEGF injection for diabetic macular edema in a Latino population
by: Guillermo Salcedo-Villanueva, et al.
Published: (2025-08-01) -
Suprachoroidal Versus Intravitreal Injection of Triamcinolone Acetonide As Primary Treatment For Diabetic Macular Edema
by: Fatima Shafqat Khan, et al.
Published: (2023-12-01) -
Optical coherence tomography findings in patients with diabetic macular edema: A retrospective analysis
by: Manjunathan Sivarasu, et al.
Published: (2025-01-01)